SEQUENT SCIENTIFIC LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.4 INR | 0.00% |
|
-1.19% | +2.20% |
| 05-16 | Transcript : Sequent Scientific Limited, Q4 2024 Earnings Call, May 16, 2024 | |
| 05-15 | Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Presenter SpeechAbhishek Singhal (Executives)Thank you for joining us today for SeQuent Scient...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
Sector
Pharmaceuticals
Calendar
2024-08-07
- Q1 2025 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.20% | 347M | |
| +34.33% | 693B | |
| +29.39% | 584B | |
| -2.92% | 372B | |
| +20.63% | 332B | |
| +6.68% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.96% | 168B |
- Stock Market
- Equities
- SEQUENT Stock
- News Sequent Scientific Limited
- Transcript : Sequent Scientific Limited, Q4 2020 Earnings Call, May 12, 2020
